Mirxes Pre-IPO: Early Signs of Commercialization Challenges
We look at fundamentals of Mirxes, including its key products, commercialization and shareholders, as it is planning to list in Hong Kong.
Pre-IPO Mirxes Holding Company - The Profit Model in the Post Pandemic Era Needs to Be Verified
After the dividend period of COVID, the deterioration of Mirxes's financial position may not be easily reversed, with survival pressure. Challenges...
Mirxes Lands US$50M to Take Its Cancer Early Detection Solutions to New Markets
Mirxes will use the capital to scale the adoption and penetration of its stomach cancer blood test, GASTROClear, in major APAC markets
No more insights